Data / Form D filings / Opus Genetics, Inc.
Opus Genetics, Inc.: Form D filings
Opus Genetics, Inc., a biotechnology company in Farmington Hills, MI, filed 2 Form D notices with the SEC between 2020 and 2024. The latest, on November 7, 2024, reports $25.8 million sold of a $25.8 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 37000 Grand River Avenue, Suite 120, Farmington Hills, MI, 48335
- Phone
- 1 (248) 957-9024
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1228627
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 7, 2024 | New notice | $25,778,641 | $25,778,641 | 11 | Oct 22, 2024 | sec.gov | |
| Nov 20, 2020 | New notice | $21,150,000 | $21,150,000 | 18 | Nov 5, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dr. Jean Bennett | Director | |
| Dr. Benjamin Yerxa | Director, Executive Officer | |
| Sean Ainsworth | Director | |
| Bernhard Hoffmann | Executive Officer | |
| Dr. Adrienne Graves | Director | |
| Richard Rodgers | Director | |
| James Manuso | Director | |
| Nirav Jhaveri | Executive Officer | |
| Ash Jayagopal | Executive Officer | |
| Cam Gallagher | Director | |
| Susan Benton | Director | |
| Amy Rabourn | Executive Officer | |
| Joseph Schachle | Executive Officer | |
| Dr. George Magrath | Director, Executive Officer |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Nov 4, 2024 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Opus Genetics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.